×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PRAX – praxis precision medicines, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PRAX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/5
10:59 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Neutral
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
12/5
09:11 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Medium
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
12/5
08:44 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at BTIG Research.
Medium
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at BTIG Research.
12/5
08:08 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "underperform" rating reaffirmed by analysts at Wedbush.
Medium
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "underperform" rating reaffirmed by analysts at Wedbush.
12/5
07:21 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
High
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/4
04:10 pm
prax
Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies
High
Report
Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies
12/4
04:01 pm
prax
Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor
High
Report
Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor
12/3
04:01 pm
prax
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2025
08:00 am
PRAX
praxis precision medicines, inc.
BEAT
Report
-4.1%
praxis precision medicines, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/21
09:42 pm
prax
Form 4 Praxis Precision Medicin For: Nov 20 Filed by: Nemiroff Alex
High
Report
Form 4 Praxis Precision Medicin For: Nov 20 Filed by: Nemiroff Alex
11/21
09:42 pm
prax
Form 4 Praxis Precision Medicin For: Nov 14 Filed by: Kelly Timothy Edwin
High
Report
Form 4 Praxis Precision Medicin For: Nov 14 Filed by: Kelly Timothy Edwin
11/21
09:40 pm
prax
Form 4 Praxis Precision Medicin For: Nov 20 Filed by: Mastrocola Lauren
High
Report
Form 4 Praxis Precision Medicin For: Nov 20 Filed by: Mastrocola Lauren
11/20
11:35 am
prax
Form 144 Praxis Precision Medicin Filed by: Nemiroff Alex
Medium
Report
Form 144 Praxis Precision Medicin Filed by: Nemiroff Alex
11/20
11:25 am
prax
Form 144 Praxis Precision Medicin Filed by: Mastrocola Lauren
Medium
Report
Form 144 Praxis Precision Medicin Filed by: Mastrocola Lauren
11/14
04:01 pm
prax
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.
Medium
Report
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.
11/14
01:08 pm
prax
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Cormorant Asset Management, LP
Medium
Report
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Cormorant Asset Management, LP
11/14
12:20 pm
prax
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Medium
Report
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: